{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:21:51Z","timestamp":1790191311254,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.beem.2025.102028","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:10:30Z","timestamp":1756480230000},"page":"102028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hyponatremia and bone pathophysiology: An integrated preclinical and clinical perspective"],"prefix":"10.1016","volume":"40","author":[{"given":"Emanuele","family":"Varaldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Potasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2025.102028_bib1","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.amjmed.2006.05.005","article-title":"Incidence and prevalence of hyponatremia","volume":"119","author":"Upadhyay","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2025.102028_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jama.2022.11176","article-title":"Diagnosis and management of hyponatremia: a review","volume":"328","author":"Adrogu\u00e9","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2025.102028_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.amjmed.2005.09.026","article-title":"Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits","volume":"119","author":"Renneboog","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2025.102028_bib4","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.ejim.2017.02.008","article-title":"Attention and postural balance are much more affected in older than in younger adults with mild or moderate chronic hyponatremia","volume":"41","author":"Renneboog","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.beem.2025.102028_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2215\/CJN.07400717","article-title":"Serum sodium and cognition in older community-dwelling men","volume":"13","author":"Nowak","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2025.102028_bib6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/cancers15041197","article-title":"Hyponatremia and cancer: from bedside to benchside","volume":"15","author":"Fibbi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2025.102028_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/qjmed\/hcn061","article-title":"Mild hyponatremia and risk of fracture in the ambulatory elderly","volume":"101","author":"Gankam Kengne","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.beem.2025.102028_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1359\/jbmr.090827","article-title":"Hyponatremia-induced osteoporosis","volume":"25","author":"Verbalis","year":"2010","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2025.102028_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00198-014-2973-1","article-title":"Hyponatremia and osteoporosis: insights from the danish national patient registry","volume":"26","author":"Kruse","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2025.102028_bib10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.mnh.0000447022.51722.f4","article-title":"Sodium homeostasis and bone","volume":"23","author":"Hannon","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.beem.2025.102028_bib11","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/jc.2015-4228","article-title":"Association between hyponatremia, osteoporosis, and fracture: a systematic review and Meta-analysis","volume":"101","author":"Upala","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102028_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/cen.13790","article-title":"Hyponatremia, falls and bone fractures: a systematic review and meta-analysis","volume":"89","author":"Corona","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.102028_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4158\/EP-2018-0499","article-title":"The effects of hyponatremia on bone density and fractures: a systematic review and meta-analysis","volume":"25","author":"Murthy","year":"2019","journal-title":"Endocr Pr"},{"key":"10.1016\/j.beem.2025.102028_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231197921","article-title":"Association of hyponatremia with bone mineral density and fractures: a narrative review","volume":"14","author":"Tzoulis","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102028_bib15","doi-asserted-by":"crossref","first-page":"e774","DOI":"10.1210\/clinem\/dgae234","article-title":"Mild hyponatremia is not associated with degradation of trabecular bone microarchitecture despite bone mass loss","volume":"110","author":"Bioletto","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102028_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11357-011-9347-9","article-title":"Chronic hyponatremia exacerbates multiple manifestations of senescence in Male rats","volume":"35","author":"Barsony","year":"2013","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.beem.2025.102028_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000493237","article-title":"Hyponatremia is linked to bone loss, osteoporosis, fragility and bone fractures","volume":"52","author":"Barsony","year":"2019","journal-title":"Front Horm Res"},{"key":"10.1016\/j.beem.2025.102028_bib18","doi-asserted-by":"crossref","first-page":"18644","DOI":"10.1073\/pnas.1318257110","article-title":"Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia","volume":"110","author":"Tamma","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2025.102028_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1073\/pnas.1523762113","article-title":"Functions of vasopressin and oxytocin in bone mass regulation","volume":"113","author":"Sun","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2025.102028_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00223-025-01369-7","article-title":"Roles of Insulin-Like growth Factor-1 in muscle wasting and osteopenia in mice with hyponatremia","volume":"116","author":"Kawao","year":"2025","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2025.102028_bib21","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 regulates bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.beem.2025.102028_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bone.2015.04.036","article-title":"Role of IGF-I signaling in muscle bone interactions","volume":"80","author":"Bikle","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.beem.2025.102028_bib23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endo-122-1-254","article-title":"Insulin-like growth factor I has independent effects on bone matrix formation and cell replication","volume":"122","author":"Hock","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2025.102028_bib24","doi-asserted-by":"crossref","first-page":"10864","DOI":"10.1074\/jbc.M110.155002","article-title":"Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss","volume":"286","author":"Barsony","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.beem.2025.102028_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111724","article-title":"Hyponatremia elicits gene expression changes driving osteoclast differentiation and functions","volume":"554","author":"Barsony","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2025.102028_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105480","article-title":"Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation","volume":"300","author":"Radvanyi","year":"2024","journal-title":"J Biol Chem"},{"key":"10.1016\/j.beem.2025.102028_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin d metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beem.2025.102028_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8821292","article-title":"FGF23: a review of its role in mineral metabolism and renal and cardiovascular disease","volume":"2021","author":"Kurpas","year":"2021","journal-title":"Dis Markers"},{"key":"10.1016\/j.beem.2025.102028_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ijos.2015.1","article-title":"Fibroblast growth factor 23 and bone mineralisation","volume":"7","author":"Guo","year":"2015","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.beem.2025.102028_bib30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","article-title":"Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro","volume":"23","author":"Wang","year":"2008","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.beem.2025.102028_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12020-015-0663-1","article-title":"Low extracellular sodium promotes adipogenic commitment of human mesenchymal stromal cells: a novel mechanism for chronic hyponatremia-induced bone loss","volume":"52","author":"Fibbi","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2025.102028_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American association of clinical Endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal Osteoporosis\u20142020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2025.102028_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s001980050008","article-title":"Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women","volume":"11","author":"Patel","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2025.102028_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/endrev\/bnac031","article-title":"Bone turnover markers: basic biology to clinical applications","volume":"44","author":"Schini","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2025.102028_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24656","article-title":"Broad application prospects of bone turnover markers in pediatrics","volume":"36","author":"Zhang","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.beem.2025.102028_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bone.2018.06.011","article-title":"Clinical utility of bone markers in various diseases","volume":"114","author":"Vlot","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.beem.2025.102028_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7150\/ijms.22747","article-title":"Bone turnover status: classification model and clinical implications","volume":"15","author":"Fisher","year":"2018","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.beem.2025.102028_bib38","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1210\/jc.2016-1183","article-title":"Diurnal rhythms of bone turnover markers in three ethnic groups","volume":"101","author":"Redmond","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102028_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/clinchem\/28.1.153","article-title":"Turnover rate of skeletal alkaline phosphatase in humans","volume":"28","author":"Posen","year":"1982","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2025.102028_bib40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00109-024-02418-8","article-title":"Current knowledge of bone-derived factor osteocalcin: its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis and inflammatory joint diseases","volume":"102","author":"Martiniakova","year":"2024","journal-title":"J Mol Med"},{"key":"10.1016\/j.beem.2025.102028_bib41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S8756-3282(01)00662-7","article-title":"Mechanism of circadian variation in bone resorption","volume":"30","author":"Bjarnason","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.beem.2025.102028_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40364-017-0097-4","article-title":"Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives","volume":"5","author":"Kuo","year":"2017","journal-title":"Biomark Res"},{"key":"10.1016\/j.beem.2025.102028_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bone.2003.04.002","article-title":"Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption","volume":"34","author":"Hannon","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.beem.2025.102028_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2025.102028_bib45","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/cen.14367","article-title":"The effects of acute hyponatraemia on bone turnover in patients with subarachnoid haemorrhage: a preliminary report","volume":"94","author":"Garrahy","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2025.102028_bib46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1053\/j.ajkd.2015.12.024","article-title":"Tolvaptan and neurocognitive function in mild to moderate chronic hyponatremia: a randomized trial (INSIGHT)","volume":"67","author":"Verbalis","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.beem.2025.102028_bib47","article-title":"The effect of normalization of sodium on bone turnover markers in patients with epilepsy. A randomized single-blinded placebo-controlled trial","volume":"19","author":"Diemar","year":"2020","journal-title":"Conte Clin Trials Commun"},{"key":"10.1016\/j.beem.2025.102028_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-21-0604","article-title":"Effect of hyponatremia normalization on osteoblast function in patients with SIAD","volume":"186","author":"Potasso","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2025.102028_bib49","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1210\/clinem\/dgad238","article-title":"An increase in plasma sodium levels is associated with an increase in osteoblast function in chronic SIAD","volume":"108","author":"Monnerat","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102028_bib50","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1210\/jc.2012-2031","article-title":"Syndrome of inappropriate ADH secretion and severe osteoporosis","volume":"97","author":"Sejling","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102028_bib51","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1210\/jc.2014-1572","article-title":"Recovery from SIADH-associated osteoporosis: a case report","volume":"99","author":"Sejling","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.102028_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-229875","article-title":"Fragility fractures and reversible osteopaenia due to chronic hyponatraemia in an adolescent Male","volume":"12","author":"Patel","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.beem.2025.102028_bib53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1210\/js.2018-00320","article-title":"Hyponatremia is associated with increased osteoporosis and bone fractures in patients with diabetes with matched glycemic control","volume":"3","author":"Usala","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.beem.2025.102028_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.coemr.2018.06.001","article-title":"Disorders of water and sodium homeostasis and bone","volume":"3","author":"Usala","year":"2018","journal-title":"Curr Opin Endocr Metab Res"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:23:38Z","timestamp":1787153018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X25000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1521690X25000612"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2025.102028","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyponatremia and bone pathophysiology: An integrated preclinical and clinical perspective","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2025.102028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102028"}}